| Incitec Pivot Limited (IPL) ORDINARY FULLY PAID |
Materials |
$4,827 |
Update - Notification of buy-back - IPL
|
12 Dec 2024 9:04AM |
$3.110 |
$2.590 |
fallen by
16.72%
|
|
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$2,443 |
Update - Notification of buy-back - NEU
|
12 Dec 2024 9:04AM |
$13.440 |
$19.290 |
risen by
43.53%
|
|
| Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$7,074 |
Rebecca Roe PFS presentation
|
12 Dec 2024 9:03AM |
$2.400 |
$3.675 |
risen by
53.13%
|
|
| Kuniko Limited (KNI) ORDINARY FULLY PAID |
Materials |
$8 |
Significant Mineral Resource Increase at Ertelien
|
12 Dec 2024 9:03AM |
$0.175 |
$0.065 |
fallen by
62.86%
|
|
KNI - Price-sensitive ASX Announcement
Full Release
Key Points
- Updated Mineral Resource Estimate completed in accordance with JORC guidelines.
- Total Mineral Resource stands at 40Mt @ 0.25% Nickel Equivalent.
- 22Mt classified as indicated resources @ 0.26% and 18Mt inferred resources @ 0.25% NiEq.
- Contained metals total 71Kt nickel, 49Kt copper, and 5.6Kt cobalt.
- Resource expansion potential identified along-strike and at depth.
- Ertelien is part of the Ringerike Battery Metals District in Southern Norway.
- Exploration efforts focused on validating historical drilling data and enhancing geological understanding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$5 |
New 1 km Zone of Gold Mineralisation Discovered at Rockland
|
12 Dec 2024 9:02AM |
$0.029 |
$0.041 |
risen by
41.38%
|
|
DUN - Price-sensitive ASX Announcement
Full Release
Key Points
- New 1 km zone of gold mineralisation discovered at Rockland.
- Assays received from a 23-hole reverse circulation drill program.
- Gold mineralisation extends over approximately 1 km along strike.
- Best intercepts include significant gold grades from multiple drill holes.
- Previous drilling was limited to 50 metres and conducted 25-35 years ago.
- Follow-up drill program is being planned to target extensions of the gold trend.
- Dundas is expecting more assay results in January 2025 from other drilling activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$291 |
Major Milestone with First Sales of Remplir in Singapore
|
12 Dec 2024 9:02AM |
$1.000 |
$1.075 |
risen by
7.50%
|
|
OCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Orthocell achieves first sales of Remplir in Singapore ahead of schedule.
- Remplir is also sold in Australia and New Zealand with growing sales.
- First sales validate the quality of the Remplir product and the strength of Device Technologies Asia.
- Singapore serves as a strategic market for expansion into ASEAN regions.
- Regulatory approval for Remplir was received in October 2024.
- The company has a strong cash position of approximately $33 million to support launches in multiple markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Immutep Limited (IMM) ORDINARY FULLY PAID |
Health Care |
$423 |
Immutep Reports Promising New Data in Head and Neck Cancer
|
12 Dec 2024 9:02AM |
$0.355 |
$0.288 |
fallen by
19.01%
|
|
IMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Median overall survival has not yet been reached and the 12-month OS rate is 67%
- Promising progression-free survival of 5.8 months
- Interim median duration of response of 9.3 months
- High objective response rate of 35.5% and disease control rate of 58.1%
- Complete response rate increases to 12.9% and 16.1% according to RECIST 1.1 and iRECIST respectively
- Efti continues to be well-tolerated with no new safety signals
- This data represents a significant improvement over historical results from anti-PD-1 therapy alone
- Immutep aims to engage with regulatory authorities regarding potential paths forward
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bindi Metals Limited (BIM) ORDINARY FULLY PAID |
Materials |
$8 |
Large Scale Antimony Zone at Mutnica
|
12 Dec 2024 9:01AM |
$0.080 |
$0.090 |
risen by
12.50%
|
|
BIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Rock chip and soil assays received at Donja Mutnica Project
- 3.3 km by 0.6 km antimony soil anomaly defined
- High-grade rock chip samples returned up to 4.5% Sb
- Kreva prospect is yet to be drill tested
- Exploration licence renewal application submitted for Donja Mutnica
- Lisa Project application is progressing
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pioneer Credit Limited (PNC) ORDINARY FULLY PAID |
Financials |
$115 |
Notice under s708A (5) (e) of the Corporations Act
|
12 Dec 2024 9:00AM |
$0.580 |
$0.715 |
risen by
23.28%
|
|
| AML3D Limited (AL3) ORDINARY FULLY PAID |
Industrials |
$94 |
AML3Ds US Technology Centre Open With Plans to Expand
|
12 Dec 2024 8:57AM |
$0.185 |
$0.170 |
fallen by
8.11%
|
|
AL3 - Price-sensitive ASX Announcement
Full Release
Key Points
- AML3D's US technology centre in Stow, Ohio is operational.
- First ARCEMY industrial metal 3D printing system installed, with a second scheduled for January 2025.
- Plans to double capacity with up to two additional ARCEMY systems.
- Secured contracts worth approximately A$16 million ahead of increased US Defence spending.
- Manufacturing capabilities support expansion into US Energy and Defence Aerospace sectors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pioneer Credit Limited (PNC) ORDINARY FULLY PAID |
Financials |
$115 |
Application for quotation of securities - PNC
|
12 Dec 2024 8:57AM |
$0.580 |
$0.715 |
risen by
23.28%
|
|
| X2M Connect Limited (X2M) ORDINARY FULLY PAID |
Information Technology |
$10 |
Trading halt
|
12 Dec 2024 8:56AM |
$0.032 |
$0.010 |
fallen by
68.75%
|
|
X2M - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by X2M Connect Limited.
- Pending announcement concerning a capital raising.
- Trading halt effective until 16 December 2024 or announcement release.
- Company believes trading halt is justified.
- Board approved the trading halt request.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$739 |
Monthly Net Tangible Asset Backing 30 November 2024
|
12 Dec 2024 8:55AM |
$2.330 |
$2.290 |
fallen by
1.72%
|
|
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$32,812 |
Notification of cessation of securities - BXB
|
12 Dec 2024 8:54AM |
$19.140 |
$24.100 |
risen by
25.91%
|
|
| Top End Energy Limited (TEE) ORDINARY FULLY PAID |
Energy |
$10 |
Investor Presentation
|
12 Dec 2024 8:54AM |
$0.105 |
$0.037 |
fallen by
64.76%
|
|
TEE - Price-sensitive ASX Announcement
Full Release
Key Points
- Transformative acquisition of a natural hydrogen project in Kansas, USA.
- Company plans to enhance its project portfolio in the natural hydrogen sector.
- Engagement with strategic partners for exploration drilling in 2025.
- Drilling efforts targeting multiple wells to capitalize on clean energy demand.
- Partnerships with top-tier clean energy investors have been established.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aristocrat Leisure Limited (ALL) ORDINARY FULLY PAID |
Consumer Discretionary |
$36,198 |
Update - Notification of buy-back - ALL
|
12 Dec 2024 8:53AM |
$67.030 |
$58.680 |
fallen by
12.46%
|
|
| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$63 |
First Kidney Transplant Trial Patient Treated
|
12 Dec 2024 8:51AM |
$0.210 |
$0.265 |
risen by
26.19%
|
|
CYP - Price-sensitive ASX Announcement
Full Release
Key Points
- Cynata Therapeutics Limited announced the treatment of the first patient with CYP-001 in a Phase 1/2 clinical trial.
- The trial is conducted by Leiden University Medical Centre.
- CYP-001 is Cynata's Cymerusâ„¢ iPSC-derived MSC product candidate.
- The primary goal is to study the safety and efficacy of CYP-001 to reduce the immunosuppressant drug tacrolimus.
- Tacrolimus is linked to significant toxicity and health risks.
- The trial aims to recruit up to 16 kidney transplant patients.
- Initial patients will receive one or two infusions of CYP-001 with standard treatment.
- The study seeks to confirm the benefits of MSC therapy in kidney transplantation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$76 |
Update - Proposed issue of securities - NMR
|
12 Dec 2024 8:51AM |
$0.031 |
$0.076 |
risen by
145.16%
|
|
| Salter Brothers Emerging Companies Limited (SB2) ORDINARY FULLY PAID |
Financials |
$62 |
Update - Notification of buy-back - SB2
|
12 Dec 2024 8:51AM |
$0.800 |
$0.735 |
fallen by
8.13%
|
|
| Great Boulder Resources Limited (GBR) ORDINARY FULLY PAID |
Materials |
$78 |
New High-Grade Gold Discovery at Mulga Bill North
|
12 Dec 2024 8:51AM |
$0.045 |
$0.075 |
risen by
66.67%
|
|
GBR - Price-sensitive ASX Announcement
Full Release
Key Points
- Multiple high-grade gold intersections discovered at Mulga Bill North.
- Notable intersections include 29m @ 3.15g/t Au and 8m @ 5.67g/t Au.
- New mineralisation aligns with the same geological unit as Mulga Bill.
- Potential for over a million ounces of gold within the 2.5km strike.
- Ongoing drilling and geochemical analysis expected in the near future.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$326 |
Update - Notification of buy-back - AMH
|
12 Dec 2024 8:50AM |
$1.200 |
$1.025 |
fallen by
14.58%
|
|
| Southern Cross Gold Ltd (SXG) ORDINARY FULLY PAID |
Materials |
- |
SXG Welcomes Victorian Government Initiatives
|
12 Dec 2024 8:49AM |
$3.770 |
$3.450 |
fallen by
8.49%
|
|
| Variscan Mines Limited (VAR) ORDINARY FULLY PAID |
Materials |
$6 |
Mineral Resource Update Investor Presentation - Dec 2024
|
12 Dec 2024 8:47AM |
$0.009 |
$0.005 |
fallen by
44.44%
|
|
| Gratifii Limited (GTI) ORDINARY FULLY PAID |
Information Technology |
$26 |
Gratifii Market Update
|
12 Dec 2024 8:46AM |
$0.105 |
$0.069 |
fallen by
34.29%
|
|
GTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Gratifii Limited reports significant growth following key acquisitions.
- Membership increased from 15 million to 23 million.
- Client base grew from 85 to 93.
- Projected revenue rose from $30 million to $84 million annually.
- The company is focusing on integrating acquisitions for enhanced service offerings.
- Strategic partnerships are in place to capitalize on market opportunities.
- A clear path to profitability is outlined with acquisition synergies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$105 |
Change of Director's Interest Notice - x3
|
12 Dec 2024 8:45AM |
$2.560 |
$2.220 |
fallen by
13.28%
|
|